Currently, Macrogenics Inc [MGNX] is trading at $2.86, up 11.72%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MGNX shares have gain 12.60% over the last week, with a monthly amount drifted -5.61%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Macrogenics Inc [NASDAQ: MGNX] stock has seen the most recent analyst activity on November 07, 2024, when JMP Securities downgraded its rating to a Mkt Perform. Previously, BTIG Research downgraded its rating to Neutral on August 01, 2024. On July 31, 2024, downgrade downgraded it’s rating to Neutral. B. Riley Securities downgraded its rating to a Neutral and decreased its price target to $5 on July 31, 2024. TD Cowen downgraded its rating to a Hold. Stifel downgraded its rating to Hold for this stock on May 10, 2024, and downed its price target to $7. In a note dated May 10, 2024, BMO Capital Markets downgraded an Market Perform rating on this stock and revised its target price from $24 to $8.
This stock has fluctuated between a low of $2.34 and a high of $21.88 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $10.33 within the next 12 months. Macrogenics Inc [NASDAQ: MGNX] shares were valued at $2.86 at the most recent close of the market. An investor can expect a potential return of 261.19% based on the average MGNX price forecast.
Analyzing the MGNX fundamentals
Trailing Twelve Months sales for Macrogenics Inc [NASDAQ:MGNX] were 141.33M which represents 964.81% growth. Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -0.76%, Pretax Profit Margin comes in at -0.69%, and Net Profit Margin reading is -0.69%. To continue investigating profitability, this company’s Return on Assets is posted at -0.37, Equity is -0.89 and Total Capital is -0.52. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.28.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.65 points at the first support level, and at 2.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.98, and for the 2nd resistance point, it is at 3.11.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Macrogenics Inc [NASDAQ:MGNX] is 3.75. Also, the Quick Ratio is 3.69, while the Cash Ratio stands at 3.03. Considering the valuation of this stock, the price to sales ratio is 1.27, the price to book ratio is 1.50.
Transactions by insiders
Recent insider trading involved Peters Jeffrey Stuart, Senior VP and General Counsel, that happened on Apr 04 ’24 when 51395.0 shares were sold. Senior VP and General Counsel, Peters Jeffrey Stuart completed a deal on Mar 06 ’24 to sell 19625.0 shares. Meanwhile, Chief Operating Officer Risser Eric Blasius sold 41159.0 shares on Mar 04 ’24.
